CJC-1295 and Ipamorelin are generally well-tolerated, but some individuals may experience mild or temporary side effects: Other possible side effects may include: These side effects are typically short-lived
It reflects average blood glucose over approximately three months and is the primary metric by which glycemic improvement is tracked in both diabetes management and weight loss programs
However, results can vary, and it's important to consult with a healthcare provider before starting
In this trial, tirzepatide is compared with dulaglutide, a pure GLP-1 receptor agonist that demonstrated a significant reduction of cardiovascular risk in the REWIND study (54)
Your provider at New Results Medical Weight Loss will determine the appropriate dose and timing based on your medical history and treatment objectives
Predictable Subcutaneous Pharmacokinetics: Provided in a stabilized pre-mixed injection pen for SubQ administration, PT-141 demonstrates reliable systemic absorption in clinical research
